Family Medicine · Ionia, MI
NPI
1831144179
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
550 E Washington St, Ste 205
Ionia, MI, 48846
Phone (616) 527-8293
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$840K
7,946 prescriptions
Company payments, 2025
$942
From 17 companies
Medicare prescription drug claims, 2024
In 2024, the drug Christopher M Ruthruff prescribed most often to Medicare patients was Atorvastatin Calcium, with 471 prescriptions and refills. In total Christopher M Ruthruff wrote 7,946 Medicare prescriptions that cost $840K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-01-19.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 471 | 1,218 | 119 | $8,194 |
| Rosuvastatin Calcium Generic | 446 | 1,147 | 118 | $11K |
| Amlodipine Besylate Generic | 348 | 913 | 90 | $3,361 |
| Lisinopril Generic | 291 | 753 | 76 | $2,787 |
| Levothyroxine Sodium Generic | 225 | 601 | 59 | $3,594 |
| Pantoprazole Sodium Generic | 199 | 448 | 58 | $3,548 |
| Omeprazole Generic | 187 | 467 | 44 | $3,105 |
| Metformin Hcl Generic | 176 | 456 | 48 | $2,158 |
| Lisinopril-Hydrochlorothiazide Lisinopril/Hydrochlorothiazide | 163 | 395 | 36 | $1,985 |
| Trazodone Hcl Generic | 163 | 320 | 41 | $2,579 |
| Metoprolol Succinate Generic | 157 | 419 | 43 | $3,682 |
| Losartan Potassium Generic | 142 | 360 | 36 | $2,305 |
| Tizanidine Hcl Generic | 141 | 181 | 50 | $1,959 |
| Tamsulosin Hcl Generic | 131 | 329 | 43 | $3,185 |
| Amlodipine Besylate-Benazepril Amlodipine Besylate/Benazepril | 129 | 339 | 34 | $3,743 |
Brand drugs: 1,020 claims; generic drugs: 6,876 claims; opioid claims: 106.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher M Ruthruff $942 ($942 in general payments such as food, travel and fees) from 17 companies. The largest payer was Novo Nordisk Inc with $217.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 10 | $217 |
| Abbvie Inc. ABBV | 7 | $140 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 6 | $135 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $78.1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $50.36 |
| Dexcom, Inc. DXCM | 2 | $48.46 |
| GlaxoSmithKline, LLC. GSK | 2 | $39.87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $33.15 |
| Axsome Therapeutics, Inc. AXSM | 1 | $33.06 |
| Exact Sciences Corporation EXAS | 2 | $29.66 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.